Join us on Thursday, October 24, for two live sessions on Tenosynovial Giant Cell Tumor. Session 1 of this series will focus on defining the type and prevalence of TGCT and the risks inherent to surgery. Listen as a patient takes part of the panel and shares their experiences and journey through care from diagnosis to management. Session 2 will discuss the impact of new and emerging targeted agents on the standard of care of patients who are not candidates for surgery.
Chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center
Stephen McDermott Chair in Surgery, Chief, Orthopaedic Surgery
Memorial Sloan Kettering Cancer Center, Professor of Orthopaedic Surgery, Weill Cornell Medical College
Watch top experts via streaming video, get the latest medical science, and earn AMA PRA Category 1 Credit™.